Citius Oncology, Inc. (CTOR) — Financial Flexibility Index
Citius Oncology, Inc. (CTOR) has a Financial Flexibility Index of -0.14x as of December 2025. Free cash flow of $-7.35 Million (operating CF $-7.35 Million minus capex $4.00) represents 0% of total liabilities ($51.56 Million). Also explore Citius Oncology, Inc. (CTOR) equity growth momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Citius Oncology, Inc. Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for Citius Oncology, Inc. across 4 annual periods. See CTOR net asset quality index to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for Citius Oncology, Inc. (2022–2025)
Year-by-year free cash flow to debt coverage for Citius Oncology, Inc.. For the full company profile including market capitalisation, see market cap of Citius Oncology, Inc..
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.10x | $-5.49 Million | $-5.49 Million | $56.08 Million | ▼ -3063.1% |
| 2024 | 0.00x | $126.36K | $126.35K | $38.23 Million | ▲ +112.2% |
| 2023 | -0.03x | $-601.30K | $-601.30K | $22.20 Million | ▼ -262.7% |
| 2022 | -0.01x | $-47.97K | $-47.97K | $6.42 Million | — |